| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Eli Lilly is experiencing a notable surge in patient inquiries driven by a promising drug pipeline that includes innovative treatments such as Retatrutide. This trend is bolstered by healthcare companies expanding their offerings, leveraging Lilly's successful launches to meet growing market demand. Moreover, advancements in pharmaceutical innovations, particularly in weight-loss and diabetes treatment, position the company favorably for future growth. The overall atmosphere is positive, with strong sentiment around the potential for continued development and market expansion. |
| The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at -0.2 is modestly bearish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for LLY since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0, and the negative at -0.2 on 2025-04-14. The forces of Valuation Sentiment (-1), and Sentiment towards Fundamentals (-0.2) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), and Market Risk Appetite (0) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| LLY | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-14 | 0%(0%) | 0 | 0% | -0.2 | -0.2 | -1 | |||||||
| 2025-04-13 | 0%(0%) | 0 | 0% | -0.5 | -1.8 | -1 | |||||||
| 2025-04-12 | 0%(0%) | 0 | 0% | -0.4 | -1.3 | -1 | |||||||
| 2025-04-11 | 0%(0%) | 0 | 0% | -0.4 | -1.3 | -1 | |||||||
| 2025-04-10 | 0%(0%) | 0 | 0% | -0.4 | -1.5 | -1 | |||||||
| 2025-04-09 | 0%(0%) | 0 | 0% | -0.6 | -2.4 | -1 | |||||||
| 2025-04-08 | 0%(0%) | 0 | 0% | -0.4 | -1.3 | -1 | |||||||
| 2025-04-07 | 0%(0%) | 0 | 0% | -0.6 | -2.4 | -1 | |||||||
| 2025-04-04 | 0%(0%) | 0 | 0% | -0.2 | -0.2 | -1 | |||||||
| 2025-04-03 | 0%(0%) | 0 | 0% | -0.3 | -0.6 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-05-19 17:08:00 The sharp increase in patient inquiries about new drugs, reflecting both market demand and the impact of successful product launches. |
| 2025-05-19 17:08:00 The fluctuating stock prices indicating investor confidence and market reactions to news concerning major pharmaceutical companies. |
| 2025-05-19 17:08:00 The dynamics between pharmaceutical companies like Eli Lilly, Novo Nordisk, and Pfizer as they react to market changes and product announcements. |
| 2025-05-19 17:08:00 The rising interest and inquiries in weight-loss medications, particularly in India following the launch of Eli Lilly's Mounjaro. |
| 2025-05-19 17:08:00 The potential imposition of tariffs on pharmaceuticals by the U.S. government, which may impact drug prices and availability. |